124 related articles for article (PubMed ID: 4616803)
1. Controlled double-blind trail of flavoxate in painful conditions of the lower urinary tract.
Baert L
Curr Med Res Opin; 1974-1975; 2(10):631-5. PubMed ID: 4616803
[TBL] [Abstract][Full Text] [Related]
2. Urinary tract disorders. Clinical comparison of flavoxate and phenazopyridine.
Gould S
Urology; 1975 May; 5(5):612-5. PubMed ID: 1093308
[TBL] [Abstract][Full Text] [Related]
3. The use of flavoxate in cystitis and renal colic.
Servedio C
Curr Med Res Opin; 1974; 2(8):449-54. PubMed ID: 4614949
[No Abstract] [Full Text] [Related]
4. Relief of bladder spasm by flavoxate. A comparative study.
Bradley DV; Cazort RJ
J Clin Pharmacol J New Drugs; 1970; 10(1):65-8. PubMed ID: 4903954
[No Abstract] [Full Text] [Related]
5. Flavoxate (Urispas).
Drug Ther Bull; 1972 Feb; 10(3):11-2. PubMed ID: 4561122
[No Abstract] [Full Text] [Related]
6. [Clinical effects of terodiline hydrochloride on urinary frequency and sense of residual urine--a double blind clinical trial using flavoxate hydrochloride as a control].
Ogawa A; Shimazaki J; Mitsuya H; Miyazaki S; Kurita T
Hinyokika Kiyo; 1988 Apr; 34(4):739-53. PubMed ID: 3041785
[TBL] [Abstract][Full Text] [Related]
7. Flavoxate hydrochloride (urispas).
Med Lett Drugs Ther; 1971 Dec; 13(26):107-8. PubMed ID: 5163920
[No Abstract] [Full Text] [Related]
8. [Treatment of diseases of the lower urinary tract and male adnexa. Trials with Spasmo-Urogenin].
Hofstetter A; Eisenberger F
Munch Med Wochenschr; 1968 Mar; 110(10):619-22. PubMed ID: 4178734
[No Abstract] [Full Text] [Related]
9. [Combined cefazolin-dicloxacillin in urology].
Tripi M; Melloni D; Rotolo U; Lamartina M; Piaia F
Minerva Urol; 1982; 34(2):105-10. PubMed ID: 7202111
[No Abstract] [Full Text] [Related]
10. [Spasmo-analgesia in urology].
Pieritz E
Med Welt; 1969 Dec; 50():2739-40. PubMed ID: 5371536
[No Abstract] [Full Text] [Related]
11. Flavoxate: present and future.
Arcaniolo D; Conquy S; Tarcan T
Eur Rev Med Pharmacol Sci; 2015; 19(5):719-31. PubMed ID: 25807422
[TBL] [Abstract][Full Text] [Related]
12. [Use of Flavoxate (Rec 7-0040) in urology].
Régua Filho Oda C
Hospital (Rio J); 1968 May; 73(5):1659-73. PubMed ID: 5308768
[No Abstract] [Full Text] [Related]
13. A comparison of emepronium bromide and flavoxate hydrochloride in the treatment of urinary incontinence.
Stanton SL
J Urol; 1973 Nov; 110(5):529-32. PubMed ID: 4750896
[No Abstract] [Full Text] [Related]
14. Traumatic lesions of the urinary tract, secondary to urologic investigations.
Burghele T
Rum Med Rev; 1965; 19(3):41-50. PubMed ID: 5842877
[No Abstract] [Full Text] [Related]
15. [Use of flavoxate in the treatment of threatened abortion and threatened premature labor].
Capra A; Paggi G
Minerva Ginecol; 1972; 24(8):400-4. PubMed ID: 4671849
[No Abstract] [Full Text] [Related]
16. [Evaluation report on spasmo-urgenin. A new urospasmolytic].
Schöll H; Reinhofer E
Med Welt; 1971 Mar; 12():471-3. PubMed ID: 4104508
[No Abstract] [Full Text] [Related]
17. [Controlled trial of drugs with antispastic and antispastic-analgesic action].
Di Carlo V
Clin Ter; 1974 Sep; 70(5):451-63. PubMed ID: 4424925
[No Abstract] [Full Text] [Related]
18. Treatment of motor urge incontinence with clenbuterol and flavoxate hydrochloride.
Grüneberger A
Br J Obstet Gynaecol; 1984 Mar; 91(3):275-8. PubMed ID: 6367811
[TBL] [Abstract][Full Text] [Related]
19. [Lower urinary tract infections in men. Urethritis, cystitis and prostatitis].
Zanella MC; Schoofs F; Huttner B; Huttner A
Rev Med Suisse; 2017 Apr; 13(558):808-814. PubMed ID: 28727330
[TBL] [Abstract][Full Text] [Related]
20. [Alpha-blockers and bioflavonoids in men with chronic nonbacterial prostatitis (NIH-IIIa): a prospective, placebo-controlled trial].
Lü M; Zhao ST; Wang SM; Shi BK; Fan YD; Wang JZ
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Feb; 25(2):169-72. PubMed ID: 15132876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
